https://www.selleckchem.com/pr....oducts/ldn-212854.ht
Consensus was reached for all statements with positive agreement higher than 85% in the first round. European psychiatrists agreed on 1) high cardiometabolic risk in patients with SSD, 2) importance of correct risk management of cardiometabolic diseases, from lifestyle modification to treatment of risk factors, including the choice of antipsychotic drugs with a favourable cardiometabolic profile. The expert panel identified the psychiatrist as the central coordinating figure of management, possibly assisted by other specialists and g
Мне нравится
Комментарий
Перепост
